ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 939

$1M Total Retail Price of All Prescriptions

Rank: 46 out of 939

881 Patients Receiving at Least One Drug in Part D
39%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 881 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 9,757 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
AMLODIPINE BESYLATE 1,414 881 1 6
SIMVASTATIN 889 429 2 2
OMEPRAZOLE 609 303 3 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 607 298 4 23
LISINOPRIL 556 249 5 3
METFORMIN HCL 483 252 6 8
HYDROCHLOROTHIAZIDE 463 227 7 12
MELOXICAM 454 207 8 14
METOPROLOL TARTRATE 435 228 9 10
FUROSEMIDE 375 200 10 7
ZOLPIDEM TARTRATE 365 129 11 20
GLYBURIDE-METFORMIN HCL 360 163 R 12 98
IBUPROFEN 334 136 13 112
POTASSIUM CHLORIDE 309 124 14 9
DIOVAN HCT 289 146 15 74
NEXIUM 281 78 16 18
GABAPENTIN 280 115 17 11
CLONIDINE HCL 255 141 18 39
LEVOTHYROXINE SODIUM 250 135 19 4
AZITHROMYCIN 242 80 20 32
PRAVASTATIN SODIUM 230 138 21 13
CYCLOBENZAPRINE HCL 222 39 R 22 36
AMLODIPINE BESYLATE-BENAZEPRIL 221 141 23 58
NAPROXEN 212 66 24 72
PROAIR HFA 202 69 25 41
ATORVASTATIN CALCIUM 199 100 26 22
TAMSULOSIN HCL 198 149 27 27
TRIAMTERENE-HCTZ 170 102 28 33
ATENOLOL 169 94 29 19
HYDROCODONE-ACETAMINOPHEN 165 81 S3 30 1
METOPROLOL SUCCINATE 162 98 31 21
TRAMADOL HCL 138 66 32 16
NIFEDIPINE ER 132 75 33 105
CLOPIDOGREL 128 67 34 28
LABETALOL HCL 122 82 35 198
SERTRALINE HCL 119 63 36 24
ALLOPURINOL 119 78 36 31
PLAVIX 118 66 38 48
DIOVAN 117 63 39 50
SYMBICORT 115 57 40 137
RANITIDINE HCL 115 16 40 35
VENTOLIN HFA 112 47 42 80
CRESTOR 106 58 43 34
PREMARIN 101 14 R 44 111
SULFAMETHOXAZOLE-TRIMETHOPRIM 98 50 45 64
GLIMEPIRIDE 98 43 45 37
VERAPAMIL ER 98 57 45 85
GLIPIZIDE 93 45 48 52
KLOR-CON M10 90 50 49 163
CARVEDILOL 90 48 49 25
ISOSORBIDE MONONITRATE ER 89 53 51 53
DIGOXIN 88 69 52 45
PHENYTOIN SODIUM EXTENDED 88 13 52 99
JANUVIA 87 26 54 110
CLOTRIMAZOLE-BETAMETHASONE 87 33 54 188
DONEPEZIL HCL 86 86 56 30
HYDRALAZINE HCL 84 52 57 130
ONGLYZA 80 50 58 241
NASONEX 76 24 59 247
EXFORGE 76 43 59 176
BENICAR HCT 74 30 61 243
LIPITOR 73 45 62 127
AMITRIPTYLINE HCL 73 20 R 62 38
TRAMADOL HCL-ACETAMINOPHEN 72 27 64 181
ADVAIR DISKUS 72 23 64 60
PREDNISONE 72 19 64 42
SPIRIVA 72 41 64 73
BYSTOLIC 72 65 64 132
SINGULAIR 71 33 69 101
KLOR-CON M20 71 48 69 90
ALENDRONATE SODIUM 71 45 69 40
FAMOTIDINE 70 46 72 62
ACETAMINOPHEN-CODEINE 70 38 S3 72 116
RAMIPRIL 68 39 74 91
INDAPAMIDE 67 46 75 173
KLOR-CON 10 63 43 76 158
RISPERIDONE 63 21 76 82
LOSARTAN POTASSIUM 62 32 78 29
POLYETHYLENE GLYCOL 3350 60 27 79 57
GLIPIZIDE ER 60 43 79 88
LANTUS SOLOSTAR 59 26 81 128
NIFEDICAL XL 59 29 81 259
DETROL LA 58 18 83 155
MECLIZINE HCL 58 45 83 134
DICLOFENAC SODIUM 57 16 85 93
FLUOCINONIDE 56 30 86 341
ENALAPRIL MALEATE 56 38 86 65
LEVOFLOXACIN 56 18 86 86
ESTRADIOL 55 17 R 89 79
WARFARIN SODIUM 54 29 90 17
PANTOPRAZOLE SODIUM 53 25 91 66
FLUCONAZOLE 52 12 92 140
NAMENDA 52 52 92 49
ACTOPLUS MET 52 30 92 343
SPIRONOLACTONE 50 19 95 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.